Suchergebnisse - "Peng, Lun"

PubPharm (11)

1

Molecular Chameleon Carriers for Nucleic Acid Delivery : The Sweet Spot between Lipoplexes and Polyplexes

enthalten in: Advanced materials (Deerfield Beach, Fla.) | 2023

von Thalmayr, S. | Grau, M. | Peng, L. | +9

2

Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC

enthalten in: Cancers | 2023

von Jie, G. | Peng, L. | Zheng, M. | +12

3

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors

enthalten in: Experimental hematology & oncology | 2021

von Peng, L. | Jie, G. | Li, A. | +13

4

Hyaluronate siRNA nanoparticles with positive charge display rapid attachment to tumor endothelium and penetration into tumors

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2021

von Luo, J. | Schmaus, J. | Cui, M. | +8

5

Universal Antifogging and Antimicrobial Thin Coating Based on Dopamine-Containing Glycopolymers

enthalten in: ACS applied materials & interfaces | 2020

von Feng, K. | Peng, L. | Yu, L. | +4

6

Delivery of Cas9/sgRNA Ribonucleoprotein Complexes via Hydroxystearyl Oligoamino Amides

enthalten in: Bioconjugate chemistry | 2020

von Kuhn, J. | Lin, Y. | Krhac Levacic, A. | +6

7

Polymeric Carriers for Nucleic Acid Delivery : Current Designs and Future Directions

enthalten in: Biomacromolecules | 2019

von Peng, L. | Wagner, E.

8

Fabrication of carbon quantum dots with nano-defined position and pattern in one step via sugar-electron-beam writing

enthalten in: Nanoscale | 2017

von Weng, Y. | Li, Z. | Peng, L. | +2

9

Chemically Modified Surface Having a Dual-Structured Hierarchical Topography for Controlled Cell Growth

enthalten in: ACS applied materials & interfaces | 2017

von Peng, L. | Zhou, S. | Yang, B. | +3

10

Integrating Sugar and Dopamine into One Polymer : Controlled Synthesis and Robust Surface Modification

enthalten in: Macromolecular rapid communications | 2017

von Peng, L. | Li, Z. | Li, X. | +3